Minerva Neurosciences

^{Priced, Nasdaq: NERV}

Clinical-stage biotech developing treatments for central nervous system diseases.

Industry: Health Care

First Day Return: +0.8%

NERV

Clinical-stage biotech developing treatments for central nervous system diseases.

IPO News for Minerva Neurosciences

US IPO Pricing Recap: Three small and discounted deals price before the holiday 07/07/14
Minerva Neurosciences prices IPO at $6 06/30/14
Minerva Neurosciences decreases proposed IPO deal size 06/30/14

IPO Data
IPO Date	06/30/2014
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$33
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.minervaneurosciences.com
Headquarters	Cambridge, MA, United States
Founded	2007
Employees at IPO	6

IPO News for Minerva Neurosciences

US IPO Pricing Recap: Three small and discounted deals price before the holiday 07/07/14
Minerva Neurosciences prices IPO at $6 06/30/14
Minerva Neurosciences decreases proposed IPO deal size 06/30/14

Minerva Neurosciences (NERV) Performance